These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 3038697

  • 1. Induction of v-mos and activated Ha-ras oncogene expression in quiescent NIH 3T3 cells causes intracellular alkalinisation and cell-cycle progression.
    Doppler W, Jaggi R, Groner B.
    Gene; 1987; 54(1):147-53. PubMed ID: 3038697
    [Abstract] [Full Text] [Related]

  • 2. Oncogenes modulate cellular gene expression and repress glucocorticoid regulated gene transcription.
    Jaggi R, Friis R, Groner B.
    J Steroid Biochem; 1988 May; 29(5):457-63. PubMed ID: 3379954
    [Abstract] [Full Text] [Related]

  • 3. Desensitization of the Ca2+-mobilizing system to serum growth factors by Ha-ras and v-mos.
    Maly K, Doppler W, Oberhuber H, Meusburger H, Hofmann J, Jaggi R, Grunicke HH.
    Mol Cell Biol; 1988 Oct; 8(10):4212-6. PubMed ID: 3141785
    [Abstract] [Full Text] [Related]

  • 4. Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells.
    Cai H, Szeberényi J, Cooper GM.
    Mol Cell Biol; 1990 Oct; 10(10):5314-23. PubMed ID: 2118993
    [Abstract] [Full Text] [Related]

  • 5. Effect of Ha-ras on phosphatidylinositol metabolism, Na+/H+-antiporter and mobilization of intracellular calcium.
    Maly K, Oberhuber H, Doppler W, Hoflacher J, Jaggi R, Groner B, Grunicke H.
    Adv Enzyme Regul; 1988 Oct; 27():121-31. PubMed ID: 2854946
    [Abstract] [Full Text] [Related]

  • 6. The v-mos and c-Ha-ras oncoproteins exert similar effects on the pattern of protein synthesis.
    Klemenz R, Hoffmann S, Jaggi R, Werenskiold AK.
    Oncogene; 1989 Jun; 4(6):799-803. PubMed ID: 2525241
    [Abstract] [Full Text] [Related]

  • 7. The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR.
    Jaggi R, Salmons B, Muellener D, Groner B.
    EMBO J; 1986 Oct; 5(10):2609-16. PubMed ID: 3023051
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 proto-oncogenes.
    Ciardiello F, Pepe S, Bianco C, Baldassarre G, Ruggiero A, Bianco C, Selvam MP, Bianco AR, Tortora G.
    Int J Cancer; 1993 Feb 01; 53(3):438-43. PubMed ID: 8094073
    [Abstract] [Full Text] [Related]

  • 9. Microinjection of ras p21 induces a rapid rise in intracellular pH.
    Hagag N, Lacal JC, Graber M, Aaronson S, Viola MV.
    Mol Cell Biol; 1987 May 01; 7(5):1984-8. PubMed ID: 3037340
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F, McGeady ML, Kim N, Basolo F, Hynes N, Langton BC, Yokozaki H, Saeki T, Elliott JW, Masui H.
    Cell Growth Differ; 1990 Sep 01; 1(9):407-20. PubMed ID: 1981145
    [Abstract] [Full Text] [Related]

  • 11. Mechanism and biological significance of the Ha-ras-induced activation of the Na+/H(+)-antiporter.
    Maly K, Hochleitner B, Uberall F, Loferer H, Oberhuber H, Doppler W, Grunicke H.
    Adv Enzyme Regul; 1990 Sep 01; 30():63-74. PubMed ID: 2169700
    [Abstract] [Full Text] [Related]

  • 12. Evidence that the time of entry into S is determined by events occurring in early G1.
    Cosenza SC, Owen TA, Soprano DR, Soprano KJ.
    J Biol Chem; 1988 Sep 05; 263(25):12751-8. PubMed ID: 3137230
    [Abstract] [Full Text] [Related]

  • 13. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters.
    Schönthal A, Herrlich P, Rahmsdorf HJ, Ponta H.
    Cell; 1988 Jul 29; 54(3):325-34. PubMed ID: 2840203
    [Abstract] [Full Text] [Related]

  • 14. Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene.
    Dartsch PC, Ritter M, Häussinger D, Lang F.
    Eur J Cell Biol; 1994 Apr 29; 63(2):316-25. PubMed ID: 8082656
    [Abstract] [Full Text] [Related]

  • 15. Lipid signalling pathways in normal and ras-transfected NIH/3T3 cells.
    Matyas GR, Fishman PH.
    Cell Signal; 1989 Apr 29; 1(4):395-404. PubMed ID: 2561989
    [Abstract] [Full Text] [Related]

  • 16. mos-induced inhibition of glucocorticoid receptor function is mediated by Fos.
    Touray M, Ryan F, Saurer S, Martin F, Jaggi R.
    Oncogene; 1991 Feb 29; 6(2):211-7. PubMed ID: 1847998
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA.
    Anticancer Res; 1985 Feb 29; 5(5):485-98. PubMed ID: 3904595
    [Abstract] [Full Text] [Related]

  • 18. Modification of Ha-ras oncogene p21 expression and cell cycle progression in the human colonic cancer cell line HT-29.
    Czerniak B, Herz F, Wersto RP, Koss LG.
    Cancer Res; 1987 Jun 01; 47(11):2826-30. PubMed ID: 3105868
    [Abstract] [Full Text] [Related]

  • 19. Different promoter elements are required for the induced expression of c-fos and c-jun proto-oncogenes by the v-mos oncogene product.
    Schönthal A, Feramisco JR.
    New Biol; 1990 Feb 01; 2(2):143-50. PubMed ID: 2150599
    [Abstract] [Full Text] [Related]

  • 20. Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain.
    Binétruy B, Smeal T, Karin M.
    Nature; 1991 May 09; 351(6322):122-7. PubMed ID: 1903181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.